6533b85ffe1ef96bd12c0e93
RESEARCH PRODUCT
pentoxifylline inhibits vgamma9/vdelta2 t lymphocyte activation of patients with active behçet's disease
Accardo Palumbo AFerrante AFrancesco CicciaMarcello CadeloGiardina ArRosalia ImpastatoGiovanni Triolosubject
pentoxifyllineBehcet s diseaseVy9/Vc>2 T lymphocyteBehcet s disease Vy9/Vc>2 T lymphocytes perforin pentoxifyllineperforindescription
The aim ofthis study is to evaluate the in vitro effect ofpentoxifylline (PTX) on T Vy9No21ymphocyte function in Beheet's disease (DO). We investigated the effect of PTX on Vy9No2 T cell expansion and expression of TNFRII receptor and perforin content before and after PTX addition by means of FACS analysis lymphocyte cultures from patients with active and inactive DO and healthy subjects. The addition of PTX at a concentration of 1 mg/ml determined a significant inhibition of cell expansion, a down regulation of TNF receptor expression and inhibited the PMA-induced degranulation of perforin. Taken together these data indicate that PTX is capable of interfering with Vy9No2 T cell function in DO, and although cell culture models cannot reliably predict all of the potential effects of the drug in vivo, our results encourage the possibility that this drug may find use in a range of immunological disorder characterized by dysregulated cell-mediated immunity
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2007-01-01 |